Geron reported $118.99M in Loan Capital for its fiscal quarter ending in June of 2025.


Loan Capital Change Date
Amgen USD 53.76B 253M Jun/2025
Bio Techne USD 346M 16M Jun/2025
Cassava Sciences USD 0 0 Dec/2024
Cytokinetics USD 713.04M 67.88M Jun/2025
Exelixis USD 0 0 Apr/2025
Genmab DKK 132M 3M Jun/2025
Geron USD 118.99M 263K Jun/2025
Gilead Sciences USD 22.14B 6M Jun/2025
Incyte USD 31.76M 883K Jun/2025
MacroGenics USD 70.26M 70.26M Jun/2025
Novartis USD 24.06B 2.4B Jun/2025